Literature DB >> 24555472

Interferon-stimulated genes: a complex web of host defenses.

William M Schneider1, Meike Dittmann Chevillotte, Charles M Rice.   

Abstract

Interferon-stimulated gene (ISG) products take on a number of diverse roles. Collectively, they are highly effective at resisting and controlling pathogens. In this review, we begin by introducing interferon (IFN) and the JAK-STAT signaling pathway to highlight features that impact ISG production. Next, we describe ways in which ISGs both enhance innate pathogen-sensing capabilities and negatively regulate signaling through the JAK-STAT pathway. Several ISGs that directly inhibit virus infection are described with an emphasis on those that impact early and late stages of the virus life cycle. Finally, we describe ongoing efforts to identify and characterize antiviral ISGs, and we provide a forward-looking perspective on the ISG landscape.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24555472      PMCID: PMC4313732          DOI: 10.1146/annurev-immunol-032713-120231

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  249 in total

1.  TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B.

Authors:  M P Myers; J N Andersen; A Cheng; M L Tremblay; C M Horvath; J P Parisien; A Salmeen; D Barford; N K Tonks
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

2.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

Review 3.  PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.

Authors:  J J Palvimo
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

4.  TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus.

Authors:  Patrick Eldin; Laura Papon; Alexandra Oteiza; Emiliana Brocchi; T Glen Lawson; Nadir Mechti
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

Review 5.  The two faces of interferon-γ in cancer.

Authors:  M Raza Zaidi; Glenn Merlino
Journal:  Clin Cancer Res       Date:  2011-06-24       Impact factor: 12.531

6.  Human leukocyte interferon: isolation and characterization of several molecular forms.

Authors:  M Rubinstein; W P Levy; J A Moschera; C Y Lai; R D Hershberg; R T Bartlett; S Pestka
Journal:  Arch Biochem Biophys       Date:  1981-08       Impact factor: 4.013

7.  Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha.

Authors:  Kevin M McBride; Gregg Banninger; Christine McDonald; Nancy C Reich
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

8.  Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.

Authors:  M You; D H Yu; G S Feng
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

9.  IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Authors:  Eric M Feeley; Jennifer S Sims; Sinu P John; Christopher R Chin; Thomas Pertel; Li-Mei Chen; Gaurav D Gaiha; Bethany J Ryan; Ruben O Donis; Stephen J Elledge; Abraham L Brass
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

10.  Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin.

Authors:  Karla J Helbig; Jillian M Carr; Julie K Calvert; Satiya Wati; Jennifer N Clarke; Nicholas S Eyre; Sumudu K Narayana; Guillaume N Fiches; Erin M McCartney; Michael R Beard
Journal:  PLoS Negl Trop Dis       Date:  2013-04-18
View more
  1030 in total

1.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Computational Systems Biology of Psoriasis: Are We Ready for the Age of Omics and Systems Biomarkers?

Authors:  Tuba Sevimoglu; Kazim Yalcin Arga
Journal:  OMICS       Date:  2015-10-19

Review 3.  Translating nucleic acid-sensing pathways into therapies.

Authors:  Tobias Junt; Winfried Barchet
Journal:  Nat Rev Immunol       Date:  2015-08-21       Impact factor: 53.106

4.  ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.

Authors:  Harini Sooryanarain; Adam J Rogers; Dianjun Cao; Mary Etna R Haac; Yogesh A Karpe; Xiang-Jin Meng
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

5.  Cholesterol 25-Hydroxylase Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication through Enzyme Activity-Dependent and -Independent Mechanisms.

Authors:  Wenting Ke; Liurong Fang; Huiyuan Jing; Ran Tao; Ting Wang; Yang Li; Siwen Long; Dang Wang; Shaobo Xiao
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

6.  Reconstitution and substrate specificity for isopentenyl pyrophosphate of the antiviral radical SAM enzyme viperin.

Authors:  Arpita Chakravarti; Kiruthika Selvadurai; Rezvan Shahoei; Hugo Lee; Shirin Fatma; Emad Tajkhorshid; Raven H Huang
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

7.  The Scaffolding Protein IQGAP1 Interacts with NLRC3 and Inhibits Type I IFN Production.

Authors:  Aaron M Tocker; Emily Durocher; Kimberly D Jacob; Kate E Trieschman; Suzanna M Talento; Alma A Rechnitzer; David M Roberts; Beckley K Davis
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

Review 8.  Taking the defensive: Immune control of Zika virus infection.

Authors:  James R Bowen; Matthew G Zimmerman; Mehul S Suthar
Journal:  Virus Res       Date:  2017-09-01       Impact factor: 3.303

9.  Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.

Authors:  Hachung Chung; Jorg J A Calis; Xianfang Wu; Tony Sun; Yingpu Yu; Stephanie L Sarbanes; Viet Loan Dao Thi; Abigail R Shilvock; H-Heinrich Hoffmann; Brad R Rosenberg; Charles M Rice
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

10.  Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.

Authors:  Suhong Qian; Wenchun Fan; Tingting Liu; Mengge Wu; Huawei Zhang; Xiaofang Cui; Yun Zhou; Junjie Hu; Shaozhong Wei; Huanchun Chen; Xiangmin Li; Ping Qian
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.